Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: CHYM position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on CHYM, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 191,757 CHYM shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 191,757 shares
    Change vs previous 13F +35,939 shares

    0.07% of the 13F portfolio, value $3,927,183.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 155,818 shares
    Change vs previous 13F -466,347 shares

    0.06% of the 13F portfolio, value $2,918,471.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 622,165 shares
    Change vs previous 13F +616,763 shares

    0.33% of the 13F portfolio, value $15,661,067.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 5,402 shares
    Change vs previous 13F +402 shares

    <0.01% of the 13F portfolio, value $108,967.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 5,000 shares
    Change vs previous 13F not available

    0.01% of the 13F portfolio, value $172,563.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).